Showing 1 - 18 results of 18 for search 'Hanaa Nafady-Hego', query time: 0.06s Refine Results
  1. 1
    Short term survival of critically ill COVID-19 Egyptian patients on assisted ventilation treated by either Dexamethasone or Tocilizumab

    Short term survival of critically ill COVID-19 Egyptian patients on assisted ventilation treated by either Dexamethasone or Tocilizumab by Alaa Rashad, Sherif Mousa, Hanaa Nafady-Hego, Asmaa Nafady, Hamed Elgendy

    Published 2021-04-01
    Get full text
    Article
  2. 2
    Perioperative management and postoperative outcome of patients undergoing cytoreduction surgery with hyperthermic intraperitoneal chemotherapy

    Perioperative management and postoperative outcome of patients undergoing cytoreduction surgery with hyperthermic intraperitoneal chemotherapy by Hamed Elgendy, Hanaa Nafady-Hego, Hanan M Abd Elmoneim, Talha Youssef, Abdulaziz Alzahrani

    Published 2019-01-01
    Get full text
    Article
  3. 3
    Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker

    Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker by Asmaa M. Zahran, Hanaa Nafady-Hego, Sawsan M. Moeen, Hanan A. Eltyb, Mohammed M. Wahman, Asmaa Nafady

    Published 2021-08-01
    Get full text
    Article
  4. 4
    Analysis of Bacterial and Fungal Infections after Cytoreduction Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Observational Single-Centre Study

    Analysis of Bacterial and Fungal Infections after Cytoreduction Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Observational Single-Centre Study by Talat A. M. Albukhari, Hanaa Nafady-Hego, Hamed Elgendy, Hanan M. Abd Elmoneim, Asmaa Nafady, Abdulaziz M. Alzahrani

    Published 2019-01-01
    Get full text
    Article
  5. 5
    Risk factors influence the arterial line patency in ICU-bound patients during COVID-19 pandemic: An observational cohort study

    Risk factors influence the arterial line patency in ICU-bound patients during COVID-19 pandemic: An observational cohort study by Hamed Elgendy, Adel Ganaw, Vipin Kumari, Vijay Settu, Prem Chandra, Hanaa Nafady-Hego, Mohamad Hilani, Hesham Ismail, Mohamed Elkateeb

    Published 2023-12-01
    Get full text
    Article
  6. 6
    Therapeutic efficacy of macrolides in management of patients with mild COVID-19

    Therapeutic efficacy of macrolides in management of patients with mild COVID-19 by Alaa Rashad, Asmaa Nafady, Mohammed H. Hassan, Haggagy Mansour, Usama Taya, Shamardan Ezzeldin S. Bazeed, Zaki F. Aref, Mennatallah Ali Abdelrhman Sayed, Hanaa Nafady-Hego, Aida A. Abdelmaksoud

    Published 2021-08-01
    Get full text
    Article
  7. 7
    SARS-CoV-2 PCR and antibody positivity among school staff at the beginning and end of the first school term

    SARS-CoV-2 PCR and antibody positivity among school staff at the beginning and end of the first school term by Moza Alishaq, Andrew Jeremijenko, Hanaa Nafady-Hego, Jameela Ali Al Ajmi, Mohamed Elgendy, Anil George Thomas, Peter V. Coyle, Hamed Elgendy, Abdul-Badi Abou-Samra, Adeel A. Butt

    Published 2021-11-01
    Get full text
    Article
  8. 8
    Azithromycin use before and during the COVID- 19 pandemic and the impact of implementing national evidence-based guidelines in Qatar

    Azithromycin use before and during the COVID- 19 pandemic and the impact of implementing national evidence-based guidelines in Qatar by Adeel A. Butt, Sherin Shams, Hanaa Nafady-Hego, Zain Bhutta, Atika Jabeen, Aimon B. Malik, Anil G. Thomas, Samah Saleem, Aftab M. Azad, Muna Almaslamani, Abdullatif Alkhal, Abdul-Badi Abou-Samra

    Published 2024-11-01
    Get full text
    Article
  9. 9
    Prognostic Role of Monocytic Myeloid-Derived Suppressor Cells in Advanced Non-Small-Cell Lung Cancer: Relation to Different Hematologic Indices

    Prognostic Role of Monocytic Myeloid-Derived Suppressor Cells in Advanced Non-Small-Cell Lung Cancer: Relation to Different Hematologic Indices by Asmaa M. Zahran, Helal F. Hetta, Zeinab Albadry M. Zahran, Alaa Rashad, Amal Rayan, Dalia O. Mohamed, Zeinab Ahmed Abd Elhameed, Salah M. Khallaf, Gaber El-Saber Batiha, Yasir Waheed, Khalid Muhammad, Hanaa Nafady-Hego

    Published 2021-01-01
    Get full text
    Article
  10. 10
    SARS-CoV-2 infection in 3,241 School working staffs: Impact of SARS CoV-2 variants of concern [Wild, B.1.1.7 and Omicron].

    SARS-CoV-2 infection in 3,241 School working staffs: Impact of SARS CoV-2 variants of concern [Wild, B.1.1.7 and Omicron]. by Moza Alishaq, Jameela Ali Al Ajmi, Mohammed Shaheen, Mohamed Elgendy, Suni Vinoy, Anil George Thomas, Sam Joseph, Tintu Elizabeth Mathew, Renjith Joseph, Christymol Thomas, Anju K Alex, Bincy Thomas, Asmaa Nafady, Hamed Elgendy, Hanaa Nafady-Hego

    Published 2023-01-01
    Get full text
    Article
  11. 11
    Spectrum of infection and outcomes in individuals with Candida auris infection in Qatar.

    Spectrum of infection and outcomes in individuals with Candida auris infection in Qatar. by Jameela A Al Ajmi, Aimon B Malik, Hanaa Nafady-Hego, Fathima Hanana, Joji Abraham, Humberto G Garcell, Ghada Hudaib, Walid Al-Wali, Faiha Eltayeb, Sherin Shams, Anil G Thomas, Samah Saleem, Abdul-Badi Abou-Samra, Adeel A Butt

    Published 2024-01-01
    Get full text
    Article
  12. 12
    Spectrum of infection and outcomes in individuals with Candida auris infection in Qatar

    Spectrum of infection and outcomes in individuals with Candida auris infection in Qatar by Jameela A. Al Ajmi, Aimon B. Malik, Hanaa Nafady-Hego, Fathima Hanana, Joji Abraham, Humberto G. Garcell, Ghada Hudaib, Walid Al-Wali, Faiha Eltayeb, Sherin Shams, Anil G. Thomas, Samah Saleem, Abdul-Badi Abou-Samra, Adeel A. Butt

    Published 2024-01-01
    Get full text
    Article
  13. 13
    Prevalence and risk factors for SARS-CoV-2 infection and seroprevalence among clinical and non-clinical staff in a national healthcare system.

    Prevalence and risk factors for SARS-CoV-2 infection and seroprevalence among clinical and non-clinical staff in a national healthcare system. by Moza Alishaq, Andrew Jeremijenko, Zeina Al-Kanaani, Hanaa Nafady-Hego, Diana H Jboor, Rosaline Saba, Jameela Al-Ajmi, Nasser Asad Alansari, Anil George Thomas, Sameera Bihi Fareh, Suni Vinoy, Maryam Nooh, Nadya Alanzi, Abdul-Badi Abou-Samra, Adeel Ajwad Butt

    Published 2021-01-01
    Get full text
    Article
  14. 14
    SARS-CoV-2 infection in mortuary and cemetery workers

    SARS-CoV-2 infection in mortuary and cemetery workers by Moza Alishaq, Andrew Jeremijenko, Hanaa Nafady-Hego, Jameela Ali Al Ajmi, Mohamed Elgendy, Rayyan Abdulaziz Attya Fadel, Anil George Thomas, Mohammed A.A. Alahmed, Adham Ammar, Meryem Bensaad, Bayan Al-Barghouthi, Peter Coyle, Hamed Elgendy, Abdul-Badi Abou-Samra, Adeel A. Butt

    Published 2021-04-01
    Get full text
    Article
  15. 15
    Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workers

    Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workers by Moza Alishaq, Hanaa Nafady-Hego, Andrew Jeremijenko, Jameela Ali Al Ajmi, Mohamed Elgendy, Suni Vinoy, Sameera Bihi Fareh, Justine Veronica Plaatjies, Mariam Nooh, Nadya Alanzi, Anvar H. Kaleeckal, Ali Nizar Latif, Peter Coyle, Hamed Elgendy, Abdul-Badi Abou-Samra, Adeel Ajwad Butt

    Published 2021-01-01
    Get full text
    Article
  16. 16
    SARS-CoV-2 infection prevalence, risk factors, and outcomes among non-clinical-related service providers in a national healthcare system

    SARS-CoV-2 infection prevalence, risk factors, and outcomes among non-clinical-related service providers in a national healthcare system by Moza Aishaq, Hanaa Nafady-Hego, Fatma Ben Abid, Jameela Ali Al Ajmi, Wedad S. Hamdi, Suni Vinoy, Anil George Thomas, Saddam Alrwashdh, Mohamed Shaheen, Tintu Elizabeth Mathew, Mohamed Elgendy, Sam Joseph, Christymol Thomas, Anju K. Alex, Asmaa Nafady, Peter V. Coyle, Hamed Elgendy

    Published 2024-12-01
    Get full text
    Article
  17. 17
    Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination

    Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination by Adeel A. Butt, MBBS, MS, Hanaa Nafady-Hego, PhD, Hiam Chemaitelly, MS, Abdul-Badi Abou-Samra, MD, PhD, Abdullatif Al Khal, MD, Peter V. Coyle, MD, Zeina Al Kanaani, PhD, Anvar H. Kaleeckal, MS, Ali Nizar Latif, MD, Yousuf Al Masalmani, MD, Roberto Bertollini, MD, Laith J. Abu Raddad, PhD

    Published 2021-09-01
    Get full text
    Article
  18. 18
    Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar

    Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar by Andrew Jeremijenko, Hiam Chemaitelly, Houssein H. Ayoub, Moza Alishaq, Abdul-Badi Abou-Samra, Jameela Ali A.A. Al Ajmi, Nasser Ali Asad Al Ansari, Zaina Al Kanaani, Abdullatif Al Khal, Einas Al Kuwari, Ahmed Al-Mohammed, Naema Hassan Abdulla Al Molawi, Huda Mohamad Al Naomi, Adeel A. Butt, Peter Coyle, Reham Awni El Kahlout, Imtiaz Gillani, Anvar Hassan Kaleeckal, Naseer Ahmad Masoodi, Anil George Thomas, Hanaa Nafady-Hego, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Nourah B.M. Younes, Hanan F. Abdul Rahim, Hadi M. Yassine, Mohamed G. Al Kuwari, Hamad Eid Al Romaihi, Mohamed H. Al-Thani, Roberto Bertollini, Laith J. Abu-Raddad

    Published 2021-05-01
    Get full text
    Article

Search Tools: